UNIVERSITY OF SOUTHERN CALIFORNIA

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1880-01-01

Employees: 10K

Market Cap: -

Website: http://startusc.com

Clinical Trials

Late Preterm Corticosteroids and Neonatal Hypoglycemia

Phase 4

Conditions: Neonatal Hypoglycemia
Prematurity

Interventions: Drug: Betamethasone Sodium Phosphate

First Posted Date: 2021-05-03

Last Posted Date: 2021-05-03

Lead Sponsor: University of Southern California

Target Recruit Count: 210

Registration Number: NCT04869709

Locations: 🇺🇸
LAC+USC Medical Center, Los Angeles, California, United States

UltraMTP in Adult Trauma Patients Undergoing Surgery Within 24 Hours: Effects on Mortality and Clinical Outcomes

Completed

Conditions: Blood Transfusion Complication
Death
Trauma

Interventions: Other: Blood transfusion

First Posted Date: 2021-04-30

Last Posted Date: 2024-03-05

Lead Sponsor: University of Southern California

Target Recruit Count: 3000

Registration Number: NCT04866953

Locations: 🇺🇸
Keck School of Medicine of the University of Southern California, Los Angeles, California, United States

Virtual Reality Guided Imagery for Chronic Pain

Not Applicable

Completed

Conditions: Back Pain
Complex Regional Pain Syndromes

First Posted Date: 2021-04-19

Last Posted Date: 2024-08-21

Lead Sponsor: University of Southern California

Target Recruit Count: 36

Registration Number: NCT04849897

Locations: 🇺🇸
USC Pain Center, Keck School of Medicine, Los Angeles, California, United States

Impact of Rifabutin on the Pharmacokinetics of Elexacaftor/Tezacaftor/Ivacaftor

Phase 4

Completed

Conditions: Drug Drug Interaction

Interventions: Drug: Trikafta [orange tablet containing ELX 100mg, TEZ 50mg, and IVA 75mg]
Drug: Rifabutin 300mg

First Posted Date: 2021-04-12

Last Posted Date: 2024-08-09

Lead Sponsor: University of Southern California

Target Recruit Count: 6

Registration Number: NCT04840862

Locations: 🇺🇸
University of Southern California, Los Angeles, California, United States

Medical and Psychosocial Issues in Adolescents and Young Adults With Colorectal Cancer

Not Applicable

Terminated

Conditions: Stage IIC Colorectal Cancer AJCC v8
Stage III Colorectal Cancer AJCC v8
Stage IIIA Colorectal Cancer AJCC v8
Stage I Colorectal Cancer AJCC v8
Stage II Colorectal Cancer AJCC v8
Stage IIA Colorectal Cancer AJCC v8
Stage IIB Colorectal Cancer AJCC v8
Stage IIIB Colorectal Cancer AJCC v8
Stage IIIC Colorectal Cancer AJCC v8
Stage IVC Colorectal Cancer AJCC v8

Interventions: Procedure: Biospecimen Collection
Other: Medical Chart Review
Other: Physical Performance Testing
Other: Quality-of-Life Assessment
Other: Questionnaire Administration

First Posted Date: 2021-04-06

Last Posted Date: 2022-08-24

Lead Sponsor: University of Southern California

Target Recruit Count: 32

Registration Number: NCT04832763

Locations: 🇺🇸
Los Angeles County-USC Medical Center, Los Angeles, California, United States
🇺🇸
USC / Norris Comprehensive Cancer Center, Los Angeles, California, United States

Dasatinib for the Treatment of Moderate and Severe COVID-19

Phase 2

Withdrawn

Conditions: Symptomatic COVID-19 Infection Laboratory-Confirmed

Interventions: Drug: Placebo Administration
Drug: Dasatinib Anhydrous

First Posted Date: 2021-04-05

Last Posted Date: 2022-08-10

Lead Sponsor: University of Southern California

Registration Number: NCT04830735

Locations: 🇺🇸
USC / Norris Comprehensive Cancer Center, Los Angeles, California, United States

Cognition and Motor Learning Post-stroke

Early Phase 1

Recruiting

Conditions: Stroke
CVA (Cerebrovascular Accident)

Interventions: Behavioral: Explicit motor learning
Behavioral: Implicit motor learning

First Posted Date: 2021-04-02

Last Posted Date: 2023-07-11

Lead Sponsor: University of Southern California

Target Recruit Count: 65

Registration Number: NCT04829071

Locations: 🇺🇸
Center for Health Professions, Los Angeles, California, United States

Monitoring Physical Activity in Hispanic Women With Chronic Neurological Disorders

Not Applicable

Completed

Conditions: Neurological Disorder

Interventions: Device: Physical Activity Monitoring Device
Behavioral: Lifestyle Redesign Coaching

First Posted Date: 2021-03-29

Last Posted Date: 2021-04-01

Lead Sponsor: University of Southern California

Target Recruit Count: 20

Registration Number: NCT04820153

Locations: 🇺🇸
University of Southern California, Los Angeles, California, United States

Simplified IMmunosuppressive Protocol Utilizing Low Dose EnvarsusXR

Phase 4

Recruiting

Conditions: Kidney Transplantation
Kidney Transplant Rejection

Interventions: Drug: Twice-daily Tacrolimus
Drug: Once-daily envarsus XR
Drug: Induction Immunosuppression with Basiliximab or Rabbit Anti Thymoglobulin (rATG)
Drug: Methylprednisolone, prednisone
Drug: Mycophenolate mofetil (MMF) or Mycophenolic acid (MPA)
Drug: Azathioprine

First Posted Date: 2021-02-26

Last Posted Date: 2023-12-05

Lead Sponsor: University of Southern California

Target Recruit Count: 80

Registration Number: NCT04773392

Locations: 🇺🇸
University of Southern California, Los Angeles, California, United States

Mobile Mindfulness for Alcohol Use and PTSD Among Veterans

Not Applicable

Completed

Conditions: Posttraumatic Stress Disorder
Alcohol Use Disorder

Interventions: Behavioral: Mobile Mindfulness-Relapse Prevention (mMBRP)
Behavioral: Exercise/healthy eating mobile app

First Posted Date: 2021-02-25

Last Posted Date: 2024-11-15

Lead Sponsor: University of Southern California

Target Recruit Count: 201

Registration Number: NCT04769986

Locations: 🇺🇸
San Francisco Veterans Affairs Healthcare System, San Francisco, California, United States
🇺🇸
National Center for PTSD, Menlo Park, California, United States
🇺🇸
University of Southern California, Los Angeles, California, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy